Drs. Kim Eagle, Deepak Bhatt, and Peter Block discuss TAVR vs. SAVR in low-risk patients (PARTNER 3 and Evolut Low Risk - 00:39); safety evaluation of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with AFib and ACS and/or PCI (AUGUSTUS - 2:55); partial oral treatment of left-sided infectious endocarditis (POET - 4:16); and a multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3 - 6:25). Visit http://www.acc.org/ACC19 for full meeting coverage.  - Acute Coronary Syndromes - 45_5feba5631406a

Day 2 Highlights | ACC.19

Day 2 Highlights | ACC.19

13 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

 

Drs. Kim Eagle, Deepak Bhatt, and Peter Block discuss TAVR vs. SAVR in low-risk patients (PARTNER 3 and Evolut Low Risk - 00:39); safety evaluation of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with AFib and ACS and/or PCI (AUGUSTUS - 2:55); partial oral treatment of left-sided infectious endocarditis (POET - 4:16); and a multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3 - 6:25). Visit http://www.acc.org/ACC19 for full meeting coverage.

 

Up Next Autoplay